© 2024 Myocardial Solutions Inc. All rights reserved.
MORRISVILLE, N.C., May 13, 2022 – The latest Multi-Ethnic Study of Atherosclerosis (MESA) article evaluates the importance of intramyocardial circumferential strain in predicting risk of heart failure and hard cardiac events.
This paper demonstrates the importance of looking at both circumferential and longitudinal strain when predicting outcomes.
In addition, MyoStrain has other advantages over traditional metrics by directly quantifying intramyocardial strain versus using global endocardial wall motion metrics to predict outcomes.
Access to the publication is available here.
Pezel T, Bluemke DA, Wu CO, Lima JAC and Ambale Venkatesh B (2022) Regional Strain Score as Prognostic Marker of Cardiovascular Events From the Multi-Ethnic Study of Atherosclerosis (MESA). Front. Cardiovasc. Med. 9:870942. https://doi.org/10.3389/fcvm.2022.870942
PR@myocardialsolutions.com
919.677.8100
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.
